175 related articles for article (PubMed ID: 30008944)
1. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.
Kanai T; Ito Z; Oji Y; Suka M; Nishida S; Takakura K; Kajihara M; Saruta M; Fujioka S; Misawa T; Akiba T; Yanagisawa H; Shimodaira S; Okamoto M; Sugiyama H; Koido S
Oncol Lett; 2018 Aug; 16(2):2682-2692. PubMed ID: 30008944
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.
Ito Z; Takakura K; Suka M; Kanai T; Saito R; Fujioka S; Kajihara M; Yanagisawa H; Misawa T; Akiba T; Koido S; Ohkusa T
Oncol Lett; 2017 Jun; 13(6):4799-4805. PubMed ID: 28599481
[TBL] [Abstract][Full Text] [Related]
3. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.
Ito Z; Kan S; Bito T; Horiuchi S; Akasu T; Yoshida S; Kajihara M; Hokari A; Saruta M; Yoshida N; Kobayashi M; Ohkusa T; Shimodaira S; Okamoto M; Sugiyama H; Koido S
Oncology; 2019; 97(3):135-148. PubMed ID: 31216557
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.
Hanada S; Tsuruta T; Haraguchi K; Okamoto M; Sugiyama H; Koido S
Hum Vaccin Immunother; 2019; 15(2):397-406. PubMed ID: 30230959
[TBL] [Abstract][Full Text] [Related]
5. Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.
Koido S; Okamoto M; Kobayashi M; Shimodaira S; Sugiyama H
Discov Med; 2017 Aug; 24(130):41-49. PubMed ID: 28950074
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.
Koido S; Okamoto M; Shimodaira S; Sugiyama H
Immunotherapy; 2016 Nov; 8(11):1309-1320. PubMed ID: 27993090
[TBL] [Abstract][Full Text] [Related]
7. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial.
Nagai K; Adachi T; Harada H; Eguchi S; Sugiyama H; Miyazaki Y
Anticancer Res; 2020 Oct; 40(10):5765-5776. PubMed ID: 32988904
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.
Qin YZ; Jiang Q; Xu LP; Jiang H; Wang Y; Zhao XS; Li ZR; Lai YY; Liu YR; Zhang XH; Liu KY; Huang XJ
Ann Hematol; 2019 Nov; 98(11):2551-2559. PubMed ID: 31493003
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
[TBL] [Abstract][Full Text] [Related]
11. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
Oji Y; Nakamori S; Fujikawa M; Nakatsuka S; Yokota A; Tatsumi N; Abeno S; Ikeba A; Takashima S; Tsujie M; Yamamoto H; Sakon M; Nezu R; Kawano K; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Oka Y; Yoshikawa K; Aozasa K; Monden M; Sugiyama H
Cancer Sci; 2004 Jul; 95(7):583-7. PubMed ID: 15245594
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis.
Lu J; Gu Y; Li Q; Zhong H; Wang X; Zheng Z; Hu W; Wen L
Medicine (Baltimore); 2018 Jul; 97(28):e11485. PubMed ID: 29995811
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma.
Guntupalli SR; Cao D; Shroff R; Gao F; Menias C; Stewart Massad L; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2013 Jul; 20(7):2373-9. PubMed ID: 23344579
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of WT1 expression at diagnosis and end of induction in Egyptian adult acute myeloid leukemia patients.
Mossallam GI; Abdel Hamid TM; Mahmoud HK
Hematology; 2013 Mar; 18(2):69-73. PubMed ID: 23394625
[TBL] [Abstract][Full Text] [Related]
16. WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.
Li BQ; Huang S; Shao QQ; Sun J; Zhou L; You L; Zhang TP; Liao Q; Guo JC; Zhao YP
Oncol Lett; 2017 Apr; 13(4):2531-2538. PubMed ID: 28454430
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis.
Yi-Ning Y; Xiao-rui W; Chu-xian Z; Chun W; You-wen Q
Ann Hematol; 2015 Jun; 94(6):929-38. PubMed ID: 25572170
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience.
Toogeh G; Ramzi M; Faranoush M; Amirizadeh N; Haghpanah S; Moghadam M; Cohan N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e21-6. PubMed ID: 26725263
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
Gaiger A; Linnerth B; Mann G; Schmid D; Heinze G; Tisljar K; Haas OA; Gadner H; Lion T
Eur J Haematol; 1999 Aug; 63(2):86-93. PubMed ID: 10480287
[TBL] [Abstract][Full Text] [Related]
20. Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.
Hendifar A; Osipov A; Khanuja J; Nissen N; Naziri J; Yang W; Li Q; Tuli R
PLoS One; 2016; 11(3):e0152172. PubMed ID: 27015568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
